Author(s)Abby Lovell, Pharma Insights Contributor, STERIS, Marketing Specialist, VHP Equipment & Consumables, John Klostermyer, Pharma Insights Contributor, STERIS, VHP Application Engineer Nephron is ...
WEST COLUMBIA, S.C. (WIS) - The FDA filed a letter warning a West Columbia pharmaceutical company to correct violations or it may face seizure or injunction. Nephron Pharmaceutical has been under ...
Figure 1: Differentiation of hPSCs into posterior intermediate mesoderm. Figure 3: Induction of pretubular aggregates and renal vesicles from nephron progenitor cells. Electron microscopy of the ...
Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...
The Clinical Implications of Basic Research series has focused on highlighting laboratory research that could lead to advances in clinical therapeutics. However, the path between the laboratory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback